KIO: High Yield Fund, Fully Covered Distribution, Currently Yielding 10% Plus
KIO currently offers a very attractive and fully covered 11.6% distribution yield. Click here to read more about KIO CEF.
Morningstar15d
KKR Income Opportunities KIO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...
Hosted on MSN29d
Kiora Pharmaceuticals secures new patent for KIO-104
KIO-104 is currently poised to enter a Phase 2 clinical trial, known as the KLARITY study, which will evaluate its efficacy in treating retinal inflammation, specifically macular edema. Macular ...